The global indapamide market is estimated to grow significantly at a CAGR of over 2.0% during the forecast period. A significant rise in the incidences of high blood pressure (hypertension) and congestive heart failure is primarily contributing to the growth of the market. High blood pressure affects approximately a third of the adult population across the globe and is the most common cause of CVD-related mortalities. As per the data published by the American Health Association (AHA) in January 2018, 103 million US adults were suffering from high blood pressure, which is nearly half of all adults in the US.

Request a free sample of our report on Indapamide Market: https://www.omrglobal.com/request-sample/indapamide-market



The global indapamide market is segmented on the basis of product and application. Based on the product, the market is bifurcated into 1.25 mg indapamide and 2.5 mg indapamide. Among these, the market for 1.25 mg medicine held a significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have a significant share in the market. Growing incidence of hypertension is contributing to the segmental growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions.

A full report of Indapamide Market Is available at https://www.omrglobal.com/industry-reports/indapamide-market

Global Indapamide Market Segmentation

By Product

1.25 MG

2.5 MG

By Application

High Blood Pressure

Heart Failure

Others

Regional Analysis

North America

US

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Company Profiles

ANI Pharmaceuticals, Inc.

Apotex Inc.

BioindustriaL.I.M. S.p.A.

Glenmark Pharmaceuticals Ltd.

Grupo Azevedos

Krka Group

Laboratori Baldacci S.p.A.

Merck KGaA

Mylan N.V.

Preferred Pharmaceuticals, Inc

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/indapamide-market

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.



For More Information, Visit https://www.omrglobal.com/



Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404